Download
s00345-020-03453-z.pdf 1,24MB
WeightNameValue
1000 Titel
  • Reasons for new MIS. Let's be fair: iTIND, Urolift and Rezūm
1000 Autor/in
  1. Suarez-Ibarrola, Rodrigo |
  2. Miernik, Arkadiusz |
  3. Gratzke, Christian |
  4. Schoeb, Dominik S. |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-09-22
1000 Erschienen in
1000 Quellenangabe
  • 39(7):2315-2327
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00345-020-03453-z |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332552/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!To review and discuss the literature regarding iTIND, Urolift and Rezūm and investigate the precise clinical indications of all three different approaches for their application in benign prostatic hyperplasia (BPH) treatment.!##!Materials and methods!#!The PubMed-Medline and Cochrane Library databases were screened to identify recent English literature relevant to iTIND, Urolift and Rezūm therapies. The surgical technique and clinical results for each approach were summarized narratively.!##!Results!#!iTIND, Urolift and Rezūm are safe and effective minimally invasive procedures for the symptomatic relief of lower urinary tract symptoms (LUTS) due to BPH. iTIND requires the results of ongoing prospective studies, a long-term follow-up and a comparison against a reference technique to confirm the generalizability of the first pivotal study. Urolift provides symptomatic relief but the improvements are inferior to TURP at 24 months and long-term retreatments have not been evaluated. Rezūm requires randomized controlled trials against a reference technique to confirm the first promising clinical results. However, clinical evidence from prospective clinical trials demonstrates the efficacy and safety of these procedures in patients with small- and medium-sized prostates.!##!Conclusions!#!Although iTIND, Urolift, and Rezūm cannot be applied to all bladder outlet obstruction (BOO) cases resulting from BPH, they provide a safe alternative for carefully selected patients who desire symptom relief and preservation of erectile and ejaculatory function without the potential morbidity of more invasive procedures.
1000 Sacherschließung
lokal Topic Paper
lokal Minimally Invasive Surgical Procedures/methods [MeSH]
lokal Humans [MeSH]
lokal Treatment Outcome [MeSH]
lokal Practice Guidelines as Topic [MeSH]
lokal Prostatic Hyperplasia/therapy [MeSH]
lokal Male urologic surgical procedures
lokal Benign prostatic hyperplasia
lokal Male [MeSH]
lokal Minimal invasive surgical procedures
lokal (MeSH terms of the US national library of medicine)
lokal Urinary tract disease
lokal Bladder outlet obstruction
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-5725-8780|https://frl.publisso.de/adhoc/uri/TWllcm5paywgQXJrYWRpdXN6|https://frl.publisso.de/adhoc/uri/R3JhdHprZSwgQ2hyaXN0aWFu|https://frl.publisso.de/adhoc/uri/U2Nob2ViLCBEb21pbmlrIFMu
1000 Hinweis
  • DeepGreen-ID: 8df1ee1c761f4699956b782aecc996e8 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
  1. Reasons for new MIS. Let's be fair: iTIND, Urolift and Rezūm
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6466862.rdf
1000 Erstellt am 2023-11-17T03:50:58.356+0100
1000 Erstellt von 322
1000 beschreibt frl:6466862
1000 Zuletzt bearbeitet Fri Dec 01 04:59:02 CET 2023
1000 Objekt bearb. Fri Dec 01 04:59:02 CET 2023
1000 Vgl. frl:6466862
1000 Oai Id
  1. oai:frl.publisso.de:frl:6466862 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source